University Hospital Basel
Basel, Switzerland
NCT Number: NCT05389228
The Swiss-AF-BURDEN study will be embedded in the follow-up visits of the Swiss-AF cohort study. The research question of the current atrial fibrillation burden will be answered by using 7-day Holter-ECG recordings and continuous implanted loop recorder recording, whereas cardiac MRI examination will give results about cardiac dimensions and function. The 7-day Holter ECG will be repeated after one year. The cMRI will be performed separately or directly after the brain MRI to minimize the additional burden for the patients. Only a subsample of 100 patients will additionally receive ILR for 2 years.
Looking for future studies?
Notify Me45 year and older
All sexes
Observational
Basel, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline to Follow-up year 2
The burden of AF is defined as the amount of time (percentage) in AF during rhythm monitoring
Time frame: Baseline to Follow-up year 2
Number of participants with overt and covert stroke
University Hospital, Basel, Switzerland
Other
Health Consequences of the Burden of Atrial Fibrillation - The Swiss-AF-BURDEN Study
Acronym: SwissAF-BURDEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04250116
Arrhythmias, Cardiac, Atrial Fibrillation
Seoul, South Korea
View Trial DetailsNCT03950076
Arrhythmias, Cardiac, Atrial Fibrillation
Elk Grove Village, Illinois, United States
View Trial DetailsNCT06436924
Arrhythmias, Cardiac, Atrial Fibrillation
Birmingham, Alabama, United States
View Trial DetailsNCT05801068
Anticoagulant-induced Bleeding, Arrhythmias, Cardiac
Seoul, Jongno-gu, South Korea
View Trial Details